F. Carey

2.8k total citations · 1 hit paper
43 papers, 2.2k citations indexed

About

F. Carey is a scholar working on Physiology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, F. Carey has authored 43 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 8 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in F. Carey's work include Colorectal Cancer Screening and Detection (5 papers), Inflammatory mediators and NSAID effects (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). F. Carey is often cited by papers focused on Colorectal Cancer Screening and Detection (5 papers), Inflammatory mediators and NSAID effects (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). F. Carey collaborates with scholars based in United Kingdom, United States and Russia. F. Carey's co-authors include Ralf Sundberg, Robert A. Forder, J.R.S. Hoult, M. José Alcaraz, Paul J. L. M. Strijbos, Jane K. Relton, Nancy J. Rothwell, R. Steele, N. Crawford and David Brewster and has published in prestigious journals such as Nucleic Acids Research, The Journal of Experimental Medicine and Gut.

In The Last Decade

F. Carey

43 papers receiving 2.2k citations

Hit Papers

Advanced Organic Chemistry 2002 2026 2010 2018 2002 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Carey United Kingdom 23 653 431 381 364 292 43 2.2k
Harold G. Parkes United Kingdom 30 960 1.5× 285 0.7× 298 0.8× 217 0.6× 179 0.6× 99 3.3k
Sumiko Inoue Japan 34 1.1k 1.7× 289 0.7× 383 1.0× 293 0.8× 156 0.5× 58 3.3k
Brigid M. Hoey United Kingdom 19 1.0k 1.6× 485 1.1× 178 0.5× 199 0.5× 136 0.5× 30 2.9k
Leonard Favreau United States 25 1.2k 1.9× 282 0.7× 134 0.4× 241 0.7× 414 1.4× 43 3.2k
Thomas A. Dix United States 30 1.6k 2.5× 554 1.3× 188 0.5× 267 0.7× 106 0.4× 71 3.2k
A. Samuni Israel 32 1.2k 1.8× 725 1.7× 147 0.4× 261 0.7× 153 0.5× 76 3.6k
I. Tong Mak United States 31 681 1.0× 292 0.7× 188 0.5× 203 0.6× 184 0.6× 86 3.1k
Michael R.L. Stratford United Kingdom 33 2.0k 3.0× 694 1.6× 476 1.2× 847 2.3× 120 0.4× 99 4.4k
Lusiane Maria Bendhack Brazil 31 689 1.1× 238 0.6× 241 0.6× 214 0.6× 251 0.9× 157 3.2k
Arnold Stern United States 34 1.8k 2.7× 254 0.6× 262 0.7× 203 0.6× 134 0.5× 115 3.8k

Countries citing papers authored by F. Carey

Since Specialization
Citations

This map shows the geographic impact of F. Carey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Carey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Carey more than expected).

Fields of papers citing papers by F. Carey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Carey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Carey. The network helps show where F. Carey may publish in the future.

Co-authorship network of co-authors of F. Carey

This figure shows the co-authorship network connecting the top 25 collaborators of F. Carey. A scholar is included among the top collaborators of F. Carey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Carey. F. Carey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chakravarty, Probir, F. Carey, Simone Weidlich, et al.. (2015). MicroRNA-224 is associated with colorectal cancer progression and response to 5-fluorouracil-based chemotherapy by KRAS-dependent and -independent mechanisms. British Journal of Cancer. 112(9). 1480–1490. 56 indexed citations
2.
Steele, R., Paula L. McClements, Christopher Watling, et al.. (2011). Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site. Gut. 61(4). 576–581. 109 indexed citations
3.
Steele, R., Paula L. McClements, Christopher Watling, et al.. (2010). Effect of repeated invitations on uptake of colorectal cancer screening using faecal occult blood testing: analysis of prevalence and incidence screening. BMJ. 341(oct27 2). c5531–c5531. 59 indexed citations
5.
Poucher, Simon M., S Freeman, J. Blake Bartlett, et al.. (2007). An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemia. British Journal of Pharmacology. 152(8). 1239–1247. 7 indexed citations
6.
Wong, Newton A C S, Rowan D. Young, Roger D. G. Malcomson, et al.. (2003). Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach. Histopathology. 43(2). 118–126. 134 indexed citations
7.
Kimber, C, et al.. (2000). Patch incorporation in diaphragmatic hernia. Journal of Pediatric Surgery. 35(1). 120–123. 26 indexed citations
8.
Craig, Stewart R., et al.. (1995). Primary small-cell cancer of the esophagus. Journal of Thoracic and Cardiovascular Surgery. 109(2). 284–288. 60 indexed citations
10.
Duncan, G S, Susan H. Peers, F. Carey, Robert A. Forder, & R.J. Flower. (1993). The local anti‐inflammatory action of dexamethasone in the rat carrageenin oedema model is reversed by an antiserum to lipocortin 1. British Journal of Pharmacology. 108(1). 62–65. 40 indexed citations
11.
Croxtall, Jamie D., Jeffrey W. Pollard, F. Carey, Robert A. Forder, & J.O. White. (1992). Colony stimulating factor-1 stimulates Ishikawa cell proliferation and lipocortin II synthesis. The Journal of Steroid Biochemistry and Molecular Biology. 42(2). 121–129. 14 indexed citations
12.
Black, Mark D., F. Carey, A.R. Crossman, Jane K. Relton, & Nancy J. Rothwell. (1992). Lipocortin-1 inhibits NMDA receptor-mediated neuronal damage in the striatum of the rat. Brain Research. 585(1-2). 135–140. 49 indexed citations
13.
Relton, Jane K., Paul J. L. M. Strijbos, C.T. O'Shaughnessy, et al.. (1991). Lipocortin-1 is an endogenous inhibitor of ischemic damage in the rat brain.. The Journal of Experimental Medicine. 174(2). 305–310. 120 indexed citations
14.
Forder, Robert A., et al.. (1990). Differential regulation of 5‐lipoxygenase and cyclo‐oxygenase pathways of arachidonate metabolism in rat peritoneal leukocytes. British Journal of Pharmacology. 101(1). 128–132. 11 indexed citations
15.
Graham, Alexander, Philip Hedge, Stephen Joseph Powell, et al.. (1989). Nucleotide sequence of cDNA for human aldose reductase. Nucleic Acids Research. 17(20). 8368–8368. 20 indexed citations
16.
Carey, F., et al.. (1988). Pro-inflammatory effects of bradykinin, Σ-cyclo[Lys1, Gly6]bradykinin and Σ-cyclo-kallidin in the rat. European Journal of Pharmacology. 156(1). 161–164. 1 indexed citations
17.
Carey, F., et al.. (1987). Partial purification and characterization of rat brain myo-inositol-1-phosphatase. Biochemical Society Transactions. 15(3). 429–430. 2 indexed citations
18.
Carey, F., et al.. (1984). Human platelet intracellular membranes: Localisation of eicosampod metabolising enzymes & site of Ca++ sequestration. Prostaglandins. 27. 43–43. 2 indexed citations
19.
Johnson, M. Ross, F. Carey, & R. M. McMillan. (1983). Alternative pathways of arachidonate metabolism: prostaglandins, thromboxane and leukotrienes.. PubMed. 19. 40–141. 49 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026